{"nct_id":"NCT05227703","title":"A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia","status":"COMPLETED","status_verified_date":"2025-04","start_date":"2022-06-30","start_date_type":"ACTUAL","primary_completion_date":"2024-08-15","primary_completion_date_type":"ACTUAL","completion_date":"2024-09-11","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}